Agile Therapeutics, Inc. announced that John Hubbard, Ph.D., FCP has been appointed to the company's board of directors, effective November 18, 2014. Dr. Hubbard will serve on Agile's Nominating and Corporate Governance Committee. Dr. John Hubbard currently serves as Senior Vice President and Worldwide Head of Development Operations for Pfizer Inc., and is responsible for the global clinical trial operations and management of more than 450 clinical projects from Phase 1 to 4.